Family Medicine & Primary Care Review
eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
1/2026
vol. 28
 
Share:
Send email
Share:
Original paper

The glycemic control of type-2 diabetic patients in the reversed referral program of Indonesia’s healthcare and social security agency: a cross-sectional study

Vitarani Dwi Ananda Ningrum
1
,
Murniati Hasibuan
1
,
Menit Ardhiani
1, 2
,
Diani Puspa Wijaya
3
,
Yosi Febrianti
1

  1. Department of Pharmacy, Islamic University of Indonesia, Yogyakarta, Indonesia
  2. Indonesian Pharmacists Association of Yogyakarta Area, Yogyakarta, Indonesia
  3. Faculty of Medicine, Islamic University of Indonesia, Yogyakarta, Indonesia
Family Medicine & Primary Care Review 2026; 28(1): 62–69
DOI: https://doi.org/10.5114/fmpcr.2026.159151
Online publish date: 2026/03/30
Article file
- 10 FM&PCR 1 26 - O - Ningrum - 1828 - The glycemic.pdf  [0.61 MB]
Get citation
 
PlumX metrics:
 
1. Home, Resources, diabetes L with, Acknowledgement, FAQs, Contact. IDF Diabetes Atlas 2021 [Internet] [cited 25.03.2025]. Available from URL: https://diabetesatlas.org/atlas/tenth-edition/.
2. ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes – 2023. Diabetes Care 2022; 46(Supplement_1): S19–S40.
3. Ningrum VDA, Ikawati Z, Sadewa AH, et al. Kontrol Glikemik dan Prevalensi Gagal Ginjal Kronik pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Wilayah Provinsi DIY Tahun 2015. Indones J Clin Pharm 2017; 6(2): 78–90 (in Indonesian).
4. Bin Rakhis SA, AlDuwayhis NM, Aleid N, et al. Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review. Cureus 2022; 14(6): e26180.
5. Kementerian Kesehatan RI. Pedoman Pelaksanaan Program Jaminan Kesehatan Nasional. Kemenkes RI; 2014 (in Indonesian).
6. Kurdi F, Abidin Z, Surya VC, et al. The Prevalence of Diabetes in Middle-Age Elderly During the COVID-19 Pandemic. JIKEP 2021; 7(2): 282–288.
7. Cigolle CT, Blaum CS, Lyu C, et al. Associations of Age at Diagnosis and Duration of Diabetes with Morbidity and Mortality Among Older Adults. JAMA Network Open 2022; 5(9): e2232766.
8. Yan Z, Cai M, Han X, et al. The Interaction Between Age and Risk Factors for Diabetes and Prediabetes: A Community-Based Cross-Sectional Study. Diabetes Metab Syndr Obes 2023; 16: 85–93.
9. Tchkonia T, Kirkland JL. Aging, Cell Senescence, and Chronic Disease: Emerging Therapeutic Strategies. JAMA 2018; 320(13): 1319–1320.
10. Chia CW, Egan JM, Ferrucci L. Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk. Circ Res 2018; 123(7): 886–904.
11. St-Onge MP, Gallagher D. Body composition changes with aging: The cause or the result of alterations in metabolic rate and macronutrient oxidation? Nutrition 2010; 26(2): 152–155.
12. Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell 2010; 9(5): 667–684.
13. Nanayakkara N, Curtis AJ, Heritier S, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia 2021; 64(2): 275–287.
14. Muilwijk M, Bolijn R, Galenkamp H, et al. The association between gender-related characteristics and type 2 diabetes risk in a multi-ethnic population: The HELIUS study. Nutr Metab Cardiovasc Dis 2022; 32(1): 142–150.
15. Sujata, Thakur R. Unequal burden of equal risk factors of diabetes between different gender in India: a cross-sectional analysis. Sci Rep 2021; 11(1): 22653.
16. Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia 2023; 66(6): 986–1002.
17. Kautzky-Willer A, Harreiter J, Pacini G. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev 2016; 37(3): 278–316.
18. Lee HR, Shin J, Han K, et al. Obesity and Risk of Diabetes Mellitus by Menopausal Status: A Nationwide Cohort Study. J Clin Med 2021; 10(21): 5189.
19. Ruze R, Liu T, Zou X, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol (Lausanne) 2023; 14: 1161521.
20. Tajdar D, Lühmann D, Fertmann R, et al. Low health literacy is associated with higher risk of type 2 diabetes: a cross-sectional study in Germany. BMC Public Health 2021; 21: 510.
21. Jalilian H, Javanshir E, Torkzadeh L, et al. Prevalence of type 2 diabetes complications and its association with diet knowledge and skills and self-care barriers in Tabriz, Iran: A cross-sectional study. Health Science Reports 2023; 6(2): e1096.
22. Duan MJF, Zhu Y, Dekker LH, et al. Effects of Education and Income on Incident Type 2 Diabetes and Cardiovascular Diseases: a Dutch Prospective Study. J Gen Intern Med 2022; 37(15): 3907–3916.
23. Lee MJ, Seo BJ, Kim YS. Impact of Education as a Social Determinant on the Risk of Type 2 Diabetes Mellitus in Korean Adults. Healthcare 2024; 12(14): 1446.
24. Sauenram N, Sillabutra J, Viwatwongkasem C, et al. Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis. PHRP 2023; 14(6): 508–519.
25. Yao X, Zhang J, Zhang X, et al. Age at diagnosis, diabetes duration and the risk of cardiovascular disease in patients with diabetes mellitus: a cross-sectional study. Front Endocrinol 2023; 14, doi: doi.org/10.3389/fendo.2023.1131395.
26. Alshahrani JA, Alshahrani AS, Alshahrani AM, et al. The Impact of Diabetes Mellitus Duration and Complications on Health-Related Quality of Life Among Type 2 Diabetic Patients in Khamis Mushit City, Saudi Arabia. Cureus 2023; 15(8): e44216, doi: 10.7759/cureus.44216.
27. Zoungas S, Woodward M, Li Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 2014; 57(12): 2465–2474.
28. Jeon JY, Lee SJ, Lee S, et al. Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program. J Diabetes Investig 2018; 9(5): 1144–1152.
29. Weiss T, Iglay K, Gulati T, et al. Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus. BMJ Open Diab Res Care 2021; 9(1): e002127, doi: 10.1136/bmjdrc-2021-002127.
30. Desai U, Kirson NY, Kim J, et al. Time to Treatment Intensification After Monotherapy Failure and its Association with Subsequent Glycemic Control Among 93,515 Patients with Type 2 Diabetes. Diabetes Care 2018; 41(10): 2096–2104.
31. Weiss T, Iglay K, Verma P, et al. 1143-P: Secondary Metformin Monotherapy Failure in Type 2 Diabetes Mellitus Patients. Diabetes 2019; 68(Supplement_1): 1143-P, doi: 10.2337/db19-1143-P.
32. Feingold KR. Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes. In: Feingold KR, Anawalt B, Blackman MR, et al., eds. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000 [cited 23.02.2025]. Available from URL: http://www.ncbi.nlm.nih.gov/books/NBK279141/.
33. Lavernia F, Adkins SE, Shubrook JH. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals. Postgraduate Medicine 2015; 127(8): 808–817.
34. Rhee SY, Kim HJ, Ko SH, et al. Monotherapy in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J 2017; 41(5): 349–356.
35. Yamazaki M, Takebe T, Hosokawa M, et al. Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real-world data from pharmacies in Japan. J Diabetes Investig 2024; 15(11): 1604–1613.
36. Abdi H, Azizi F, Amouzegar A. Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review. Int J Endocrinol Metab 2018; 16(2): e65600.
37. Goudswaard AN, Furlong NJ, Valk GD, et al. Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus. Cochrane Database Syst Rev 2004; 2004(4): CD003418.
38. Lee BW, Kim JH, Ko SH, et al. Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017. Diabetes Metab J 2017; 41(5): 367–373.
39. Perkeni (Indonesian Association of Endocrinologists). Pedoman Petunjuk Praktis Terapi Insulin pada Pasien Diabetes Melitus [Internet]. PB PERKENI; 2021. Available from URL: https://pbperkeni.or.id/wp-content/uploads/2021/ (in Indonesian).
40. Ewid M, Algoblan AS, Elzaki EM, et al. Factors associated with glycemic control and diabetes complications in a group of Saudi patients with type 2 diabetes. Medicine (Baltimore) 2023; 102(38): e35212.
41. Riaz F, Al Shaikh A, Anjum Q, et al. Factors related to the uncontrolled fasting blood sugar among type 2 diabetic patients attending primary health care center, Abha city, Saudi Arabia. Int J Clin Pract 2021; 75(7): e14168.
42. Alsaidan AA, Alotaibi SF, Thirunavukkarasu A, et al. Medication Adherence and its Associated Factors among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers of Eastern Province, Saudi Arabia. Medicina 2023; 59(5): 989.
43. Mannan A, Hasan MM, Akter F, et al. Factors associated with low adherence to medication among patients with type 2 diabetes at different healthcare facilities in southern Bangladesh. Global Health Action 2021; 14(1): 1872895.
44. Khardali A, Kashan Syed N, Alqahtani SS, et al. Assessing medication adherence and their associated factors amongst type-2 diabetes mellitus patients of Jazan Province, Saudi Arabia: A single-center, cross-sectional study. Saudi Pharm J 2024; 32(1): 101896.
45. Venditti V, Bleve E, Morano S, et al. Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites 2023; 13(10): 1087.
46. Chesser AK, Keene Woods N, Smothers K, et al. Health Literacy and Older Adults. Gerontol Geriatr Med 2016; 2: 2333721416630492.
47. Hamalaw S, Hama Salih A, Weli S. Non-adherence to Anti-diabetic Prescriptions Among Type 2 Diabetes Mellitus Patients in the Kurdistan Region of Iraq. Cureus 2024; 16(5): e60572.
48. Saraiva EMS, Coelho JLG, dos Santos Figueiredo FW, et al. Medication non-adherence in patients with type 2 diabetes mellitus with full access to medicines. J Diabetes Metab Disord 2020; 19(2): 1105–1113.
49. Ellis K, Mulnier H, Forbes A. Perceptions of insulin use in type 2 diabetes in primary care: a thematic synthesis. BMC Family Practice 2018; 19(1): 70.
50. Sağlam FS, Bektas H. Risk perceptions of patients with type 2 diabetes mellitus regarding insulin therapy and diabetes complications: A cross-sectional study. J Clin Nurs 2023; 32(15–16): 5010–5027.
51. Saleem A, Masood I, Khan TM. Insulin perception among insulin-naïve type-2 diabetes mellitus patients in Pakistan. Cogent Med 2016; 3(1): 1229374.
52. Boye KS, Thieu VT, Lage MJ, et al. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study. Adv Ther 2022; 39(5): 2208–2221.
53. Wu TE, Su YW, Chen HS. Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2022; 192: 110069.
54. Ojo OA, Ibrahim HS, Rotimi DE, et al. Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology. Med Nov Technol Devices 2023; 19: 100247.
55. Alzahrani AM, Alshareef RJ, Balubaid MM, et al. Perception and attitude of type 2 diabetic patients toward insulin therapy in the primary care of National Guard for Health Affairs (NGHA) in Jeddah, Saudi Arabia. J Family Med Prim Care 2023; 12(11): 2768–2773.
Copyright: © 2026 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.